Find your next paid study

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT05116930

Aortic Valve StenosisAortic StenosisAortic Valve Disease

Controlled Arterial Protection to Ultimately Remove Embolic Material

The objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus…

~$10 – $1,050

Actual pay is set by the research site.

EmStop IncNCT07276711

Non-Nutritive Sweeteners, Glucose Homeostasis, and the Gut Microbiome in Prediabetes

This pilot study will evaluate the feasibility and acceptability of a 30-day sucralose intervention among adults with prediabetes. Participants will consume si…

Prediabetes

Tufts UniversityNCT07868432

Actual pay is set by the research site.

Clinical Performance Evaluation of Two Monthly Replacement Silicone Hydrogel Multifocal Toric Lens Designs in Habitual Soft Contact Lens Wearers

To compare the performance of two leading soft multifocal Toric contact lenses.

AstigmatismMyopia

CooperVision International Limited (CVIL)NCT07829419

~$10 – $1,050

Actual pay is set by the research site.

Phase 4

Effects of NAD Restoration on Neurovascular Coupling in Community Dwelling Older Adults

Daily consumption of one of the forms of Vitamin B3, the Nicotinamide Riboside (NR), energizes the body and combats cellular aging. This study is designed to t…

Aging

University of OklahomaNCT05483465

~$25 – $1,000

Actual pay is set by the research site.

Phase 2

An Extension Study to Evaluate the Long-term Safety and Efficacy of Afimkibart (RO7790121) in Patients With Rheumatoid Arthritis Who Participated in Previous Afimkibart Clinical Trials

The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis …

Rheumatoid Arthritis

Hoffmann-La RocheNCT07620392

~$75 – $3,000

Actual pay is set by the research site.

Outcome Reflection for Immune Mediated Rejection by Utilizing Artificial Intelligence in Cardiac Transplant Patients Through Early and Late Echocardiographic Analysis (ORACLE)

The purpose of this research is to detect episodes of rejection versus non-rejection after cardiac transplant and the diagnostic accuracy of an Artificial Inte…

Cardiac Transplant Rejection

Actual pay is set by the research site.

Mayo ClinicNCT06178744

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

The purpose of the study is to learn more about ways to help patients understand and manage side-effects from hormone therapy. The investigators will use the i…

Cancer

Abramson Cancer Center at Penn MedicineNCT07454499

Actual pay is set by the research site.

Phase 3

A Randomized, Double-blind, Parallel Group Phase 3 Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (PERSIST CRSwNP-2)

The aim of this study is to assess the efficacy and safety of GSK5784283 administered as add-on maintenance therapy to participants with CRSwNP.

Nasal Polyps

GlaxoSmithKlineNCT07782957

~$50 – $2,250

Actual pay is set by the research site.

Phase 1

A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma

The goal of this clinical research study is to learn about the safety and tolerability of the OnVagus device when used by patients who have metastatic pancreat…

Metastatic Pancreatic Adenocarcinoma

M.D. Anderson Cancer CenterNCT07700212

~$150 – $3,000

Actual pay is set by the research site.

Registry of Patients With Bone Disorders

The purpose of this study is to create an electronic registry to house phenotypic information from patients with achondroplasia. The initial focus of this regi…

Achondroplasia

Johns Hopkins UniversityNCT02597881

Actual pay is set by the research site.

Phase 2

A Randomized Phase 2/3 Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma (HARMONi-GU1)

A Randomized, Open-Label, Multicenter, Phase 2/3 Clinical Study of Ivonescimab in Combination with Enfortumab Vedotin vs Pembrolizumab in Combination with Enfo…

Metastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma (UC)